Fox Chase Cancer Center

09/24/2024 | Press release | Distributed by Public on 09/24/2024 17:26

Fox Chase Cancer Center Welcomes Dr. Hilario Yankey

September 24, 2024
Hilario Yankey, MD, MBA, has joined Fox Chase Cancer Center as an Assistant Professor in the Department of Radiation Oncology.

PHILADELPHIA (September 24, 2024) - Fox Chase Cancer Center is pleased to announce the hiring of Hilario Yankey, MD, MBA, as an Assistant Professor in the Department of Radiation Oncology.

Yankey begins serving in this role following his completion of the Radiation Oncology Residency and Fellowship Training Program at Fox Chase in June. He was Chief Resident of the program from 2022 through 2023.

Prior to his arrival at Fox Chase, he completed his internal medicine transitional training at Crozer Chester Medical Center in Upland, Pennsylvania. He earned his medical degree from the Lewis Katz School of Medicine at Temple University. He also has a Master of Business Administration in Healthcare Management degree from Widener University School of Business.

At Fox Chase, Yankey will specialize in gynecologic cancers and some general radiation oncology. He has contributed to over fifteen publications and presentations on cancers of the biliary tract, rectum, anus and prostate.

Yankey has volunteered for a number of initiatives, including The Free Clinic at Temple, a COVID-19 Vaccine Clinic, as a student ambassador to the Drexel Minority Association of Pre-Med Students, and as a student ambassador to under-represented minority interviewees at the Lewis Katz School of Medicine.

Yankey is a member of several professional organizations, including the American Urological Association, the American Society for Radiation Oncology, and the American Brachytherapy Society.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation's first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center's nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427